Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06977399

The Application Value of Spectral CT in the Accurate Staging of Liver Cancer

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Yunnan Cancer Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Spectral CT was used to prospectively collect medical images and clinical data related to liver cancer, evaluate the effect of image quality in the diagnosis of liver cancer, and evaluate the application value in the accurate staging of liver cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTo explore the value of spectral CT in the diagnosis and treatment of liver cancerThe CT scan is part of the standard treatment protocol.

Timeline

Start date
2025-06-01
Primary completion
2026-05-31
Completion
2026-05-31
First posted
2025-05-18
Last updated
2025-05-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06977399. Inclusion in this directory is not an endorsement.

The Application Value of Spectral CT in the Accurate Staging of Liver Cancer (NCT06977399) · Clinical Trials Directory